|
Primary outcome measure:
|
|
1.
|
Primary outcome: assessment of functional outcome over the entire range of the mRS
|
|
2.
|
Co-primary outcome: assessment of functional outcome including the following range of outcomes: mRS 0–3 if available, mRS 4–5 or (if mRS is missing) living in institution (information according registration office at 4 months after stroke), and death
|
|
Secondary outcome measures:
|
|
1.
|
Thrombolysis rate
|
|
2.
|
Endovascular thrombectomy rate
|
|
3.
|
Onset-to-treatment time
|
|
4.
|
Onset-to-reperfusion time (for endovascular thrombectomy, Charité centers only)
|
|
5.
|
Alarm-to-imaging time
|
|
6.
|
Alarm-to-treatment time
|
|
7.
|
Imaging-to-treatment time
|
|
8.
|
Cost effectiveness (additional costs due to implementation and running of STEMO, duration of hospital stay regarding acute treatment and rehabilitation, hospital related costs, costs of long-term care, and combination of above mentioned)
|
|
9.
|
Quality of life (EQ-5D)
|
|
10.
|
Shift analyses for mRS ≤ 1 at 3 months in patients ≤80 years of age living at home without disability and mRS ≤ 2 at 3 months in patients > 80 years of age living at home with help or living in an institution
|
|
11.
|
Secondary ICH after thrombolysis or thrombectomy
|
|
12.
|
Symptomatic secondary ICH according to the discharge letter
|
|
13.
|
In-hospital mortality
|
|
14.
|
Death rate over time (Kaplan-Meier plot)
|
|
15.
|
Discharge status (including in-hospital mortality among patients not included in the primary study population, especially patients with ICH)
|
|
16.
|
Functional outcome among patients with ICH
|
|
17.
|
Rate of emergency medical service deliveries to specialized facilities (patients with large vessel occlusion to endovascular thrombectomy capable facility, patients with ICH to neurosurgery department)
|
